Elevated β-catenin pathway as a novel target for patients with resistance to EGF receptor targeting drugs.
Nakata A, Yoshida R, Yamaguchi R, Yamauchi M, Tamada Y, Fujita A, Shimamura T, Imoto S, Higuchi T, Nomura M, Kimura T, Nokihara H, Higashiyama M, Kondoh K, Nishihara H, Tojo A, Yano S, Miyano S, Gotoh N.
Nakata A, et al.
Sci Rep. 2015 Aug 13;5:13076. doi: 10.1038/srep13076.
Sci Rep. 2015.
PMID: 26268703
Free PMC article.